Featured Stories

Explore inspiring journeys of recovery and resilience as patients share their experiences with Padaav’s root-cause-focused, evidence-based Ayurvedic treatments, highlighting the power of personalized care and holistic healing.

Sumit Kumar

Sumit suffered from Pancreas Divisum, a congenital anomaly where the two pancreatic ducts (the ve…




Dehradun, Uttarakhand

Ved Hitendra Kumar Vyas

Ahmedabad, India — At 18, Ved Hitendra Kumar Vyas, an engineering student from Ahmedabad, w…




Ahmedabad, Gujarat

Aditya Jain

Ahmedabad, Gujarat, India — At the age of 15, Aditya Jain, a student from Ahmedabad, faced …




Ahmedabad, Gujarat

Ketan Kamdar

Ketan’s struggle with Pancreatitis began when he was just 20 years old and a student. It st…

Sonali Dixit

My name is Sonali Dixit, and I want to share my long and arduous journey with pancreatitis. It&rs…




Noida, Uttar Pradesh

Jaswinder Singh

Jaswinder Singh, a 45-year-old businessman running a petrol pump in the small village of Ratanpur…




Rantapura, Uttarakhand

All Stories

Delve into the heartfelt experiences of patients who have transformed their health and lives with Padaav’s research-backed Ayurvedic care, showcasing the impact of addressing root causes for lasting recovery.

Hamad Alam

Rectal Adenocarcinoma




New Delhi

Hamad’s struggle reached a terrifying peak in 2018 while traveling back to Delhi from a cou…

Shilipi

Acute Recurrent Pancreatitis




Kotdwar, Uttarakhand.

Shilpi’s struggle began suddenly during her 10th-grade school break, when she felt a sharp …

Anurag Goyal

Investment Banker




New Delhi

Anurag’s struggle began suddenly in the midnight of September 2010, when he experienced exc…

Sumit Kumar

Sumit Kumar

Pancreas Divisum with secondary Chronic Pancreatitis




Dehradun, Uttarakhand

Sumit suffered from Pancreas Divisum, a congenital anomaly where the two pancreatic ducts (the ve…

Aviral Saxena

Aviral Saxena

Chronic Pancreatitis with Secondary Diabetes




Dehradun, Uttarakhand

Aviral’s journey began in November 2022 while he was actively working as a freelancer. The …

Rajeev Sharma

Chronic Pancreatitis




Dehradun, Uttarakhand

Rajeev’s journey began with mild symptoms in 2009, potentially following a physical encount…

Our Research

At Padaav, alongside delivering unparalleled patient care and promoting holistic health, we are committed to advancing Ayurveda by actively participating in research and contributing to its growing body of knowledge.

Transformation of Copper into therapeutic mineral complex following principles of Rasa Shastra

Transformation of Copper into therapeutic mineral complex following principles of Rasa Shastra

Rasa Shastra, an Ayurvedic branch, transforms toxic substances into safe therapeutics. A compound using Copper, Mercury, Sulphur, Luffa echinata, Clitoria ternatea, and lemon juice was effective in treating pancreatic disorders. The 2015-17 study developed standard procedures and analyzed the compound, revealing new mineral forms and no free metals. This demonstrates the potential of traditional methods in safely converting metals into effective treatments.

Impact Evaluation of Ayurvedic Treatment Protocol on Three HundredNineteen Cases of Different Variants of Pancreatitis

Impact Evaluation of Ayurvedic Treatment Protocol on Three HundredNineteen Cases of Different Variants of Pancreatitis

Pancreatitis, affecting the pancreas' function, causes symptoms like pain, nausea, and weight loss. Conventional treatments are limited, prompting many to seek alternative medicine. A North India Ayurvedic clinic successfully treated 319 cases of Recurrent Acute/Chronic Pancreatitis using a specialized Ayurvedic Treatment Protocol (ATP), including the formulation Amar. This treatment improved weight and reduced attack frequency without side effects. Ongoing research is exploring its potential.

Changing Demography of Pancreatitis Patients in India -A Hospital Based Study

Changing Demography of Pancreatitis Patients in India -A Hospital Based Study

Pancreatitis is rising globally, with major risk factors including alcohol, tobacco, and family history. A study of 800 patients in North India found higher incidences among non-alcoholic, non-tobacco users, and those with no family history. The disease mostly affected men (4.6:1) aged 19-45, particularly in the service class and students. Further research is needed to explore its causes and extent in the region.

Acute Promyelocytic Leukemia: 37 Years Long Ongoing Survival in a de novo Patient with Metal-Based Ayurvedic Treatment

Acute Promyelocytic Leukemia: 37 Years Long Ongoing Survival in a de novo Patient with Metal-Based Ayurvedic Treatment

Acute promyelocytic leukemia (APML) is a subtype of leukemia marked by anemia, infections, and bleeding. It is diagnosed through bone marrow tests and the PML-RARα fusion gene. Recent treatments with ATRA and arsenic trioxide have improved survival rates, but challenges like side effects and relapses remain. A 1982 case of a patient who survived 37 years without standard treatment suggests potential alternative therapies.

Clinical Intervention of Ayurvedic Treatment in the Patients of Recurrent Acute/Chronic Pancreatitis

Clinical Intervention of Ayurvedic Treatment in the Patients of Recurrent Acute/Chronic Pancreatitis

The study of 1233 acute pancreatitis patients found that 12.9% experienced oral feeding intolerance (OFI). Risk factors included younger age, male sex, alcohol use, smoking, non-biliary etiology, and SIRS at 48h. SIRS at 48h (OR 2.85) and non-biliary etiology (OR 1.77) were independently linked to OFI, with biliary etiology being protective.

Proof of Efficacy Study to Evaluate an Ayurvedic Formulation in the Treatment of Allergic Rhinitis: An Open Label Randomized Controlled Clinical Trial

Proof of Efficacy Study to Evaluate an Ayurvedic Formulation in the Treatment of Allergic Rhinitis: An Open Label Randomized Controlled Clinical Trial

A study on 250 patients compared the Ayurvedic formulation IMMBO to a levocetirizine-montelukast combination for allergic rhinitis. IMMBO showed significantly greater improvements in symptoms (TNSS: -5.70 vs. -3.31) and IgE reduction (-351.54 vs. -208.79), demonstrating superior efficacy and safety.